ODI Pharma AB (publ) (NGM:ODI)
Sweden · Delayed Price · Currency is SEK 2.260
-0.080 (-3.42%)
At close: Sep 3, 2026
ODI Pharma AB Ratios and Metrics
Market cap in millions SEK. Fiscal year is July - June.
Millions SEK. Fiscal year is Jul - Jun.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 41 | 44 | 35 | 110 | 84 | 82 | |
Market Cap Growth | 60.28% | 26.80% | -68.34% | 30.91% | 1.85% | 21.08% |
Enterprise Value | 38 | 40 | 33 | 104 | 80 | 73 |
Last Close Price | 2.26 | 2.40 | 2.18 | 7.20 | 5.50 | 5.40 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
PE Ratio | 20.84 | 22.13 | - | - | - | - |
PS Ratio | 1.26 | 1.34 | 11.07 | 4.92 | 600.26 | 262.63 |
PB Ratio | 17.44 | 18.52 | 81.70 | 54.76 | 32.54 | 8.87 |
P/TBV Ratio | 17.44 | 18.52 | 81.70 | 54.76 | 32.54 | 8.87 |
P/FCF Ratio | 9.05 | 9.61 | - | - | - | - |
P/OCF Ratio | 9.05 | 9.61 | - | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
EV/Sales Ratio | 1.16 | 1.21 | 10.43 | 4.65 | 573.75 | 233.92 |
EV/EBITDA Ratio | 15.16 | 15.86 | - | 240.49 | - | - |
EV/EBIT Ratio | 15.19 | 15.89 | - | 242.14 | - | - |
EV/FCF Ratio | 8.31 | 8.70 | - | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Net Debt / Equity Ratio | -1.43 | -1.43 | -3.49 | -1.32 | -2.52 | -0.79 |
Net Debt / EBITDA Ratio | -1.35 | -1.35 | 0.27 | -6.13 | 0.95 | 1.02 |
Net Debt / FCF Ratio | -0.74 | -0.74 | 0.45 | 0.69 | 1.27 | 1.00 |
Asset Turnover | 6.64 | 6.64 | 0.37 | 2.18 | 0.02 | 0.02 |
Inventory Turnover | - | - | - | - | 0.77 | 0.34 |
Quick Ratio | 1.51 | 1.51 | 0.71 | 1.14 | 1.30 | 6.84 |
Current Ratio | 1.81 | 1.81 | 0.86 | 1.20 | 1.46 | 8.49 |
Return on Equity (ROE) | 141.98% | 141.98% | -489.19% | -24.84% | -116.63% | -56.64% |
Return on Assets (ROA) | 31.59% | 31.59% | -40.47% | 2.62% | -45.57% | -32.91% |
Return on Invested Capital (ROIC) | - | - | - | - | - | -402.96% |
Return on Capital Employed (ROCE) | 105.40% | 105.40% | -1283.70% | 21.40% | -264.80% | -77.80% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Earnings Yield | 4.80% | 4.52% | -17.10% | -0.52% | -8.24% | -8.81% |
FCF Yield | 11.05% | 10.40% | -9.53% | -3.49% | -6.10% | -8.98% |
Buyback Yield / Dilution | 1.14% | 1.14% | -21.82% | 0.76% | -1.69% | 1.52% |